enGene Therapeutics Inc. Common Stock (ENGN)

Typically moves ±4.86% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-09-10 ESTIMATED

enGene Therapeutics Inc. Common Stock (ENGN) has reported earnings 10 times since Mar 11, 2024. The stock moves an average of ±4.86% the day after reporting, closing higher 40.0% of the time. Its largest post-earnings gain was +4.05% (Dec 22, 2025) and its largest decline was -18.97% (Mar 09, 2026). The next earnings report is predicted for 2026-09-10 (estimated).

Earnings reactions

How ENGN moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.86%

Positive %

40.0%

Negative %

60.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Jun 15, 2026	☽ POST	-0.85%	—
Mar 09, 2026	☀ PRE	-18.97%	open_in_new
Dec 22, 2025	☽ POST	+4.05%	open_in_new
Sep 11, 2025	☽ POST	-6.9%	open_in_new
Jun 12, 2025	☀ PRE	-2.8%	open_in_new
Mar 10, 2025	☽ POST	+0%	open_in_new
Dec 19, 2024	☽ POST	-1.37%	open_in_new
Sep 10, 2024	☽ POST	+3.62%	open_in_new
Jun 14, 2024	☀ PRE	-10.04%	open_in_new
Mar 11, 2024	☽ POST	+0%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.86%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 9 →

Funds holding

$6165686

Total value held

Buying

9 added · 0 reduced

Ameriprise Financial Inc

$4629266 NEW BUY

Ubs Group Ag

$880721 NEW BUY

Barclays Plc

$488751 NEW BUY

Morgan Stanley

$57239 NEW BUY

Raymond James Financial Inc

$36946 NEW BUY

SEC Filing Types

description 4

8 chevron_right

description SCHEDULE 13G/A

7 chevron_right

description 8-K

5 chevron_right

description SCHEDULE 13G

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
SCHEDULE 13G/A	20260812	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
3	20260722	open_in_new SEC.gov
3	20260722	open_in_new SEC.gov
SCHEDULE 13G	20260722	open_in_new SEC.gov
8-K	20260717	open_in_new SEC.gov

Frequently asked about ENGN earnings

When does enGene Therapeutics Inc. Common Stock report earnings next? expand_more

enGene Therapeutics Inc. Common Stock (ENGN)'s next earnings date is estimated for 2026-09-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ENGN stock move after earnings? expand_more

Over 10 reports, ENGN has moved an average of ±4.86% the session after earnings, closing higher 40.0% of the time.

What was ENGN's biggest post-earnings move? expand_more

ENGN's largest post-earnings gain on record was +4.05% on Dec 22, 2025, and its largest decline was -18.97% on Mar 09, 2026.

Where can I find enGene Therapeutics Inc. Common Stock's SEC filings? expand_more

All of enGene Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.